-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 ScRN0eIrsj28zHahR5H0AFDLxMULo73MJaeNsdpnvNHPixeWA3byVARq6BQBuH3b
 CGZxthYzY+hVMyD6ecBaeg==

<SEC-DOCUMENT>0000012208-08-000039.txt : 20081022
<SEC-HEADER>0000012208-08-000039.hdr.sgml : 20081022
<ACCEPTANCE-DATETIME>20081022144450
ACCESSION NUMBER:		0000012208-08-000039
CONFORMED SUBMISSION TYPE:	25
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20081022
DATE AS OF CHANGE:		20081022
EFFECTIVENESS DATE:		20081022

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO RAD LABORATORIES INC
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		081135152

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DR
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000
</SEC-HEADER>
<DOCUMENT>
<TYPE>25
<SEQUENCE>1
<FILENAME>form25.htm
<TEXT>
<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>NOTIFICATION OF REMOVAL FROM LISTING AND/OR</TITLE>
<META NAME="author" CONTENT="Authorized User">
<META NAME="date" CONTENT="10/21/2008">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000">
<DIV style="width:576px"><P style="line-height:18.667px; margin:0px; font-size:16px" align=center><B>NOTIFICATION OF REMOVAL FROM LISTING AND/OR</B></P>
<P style="line-height:18.667px; margin:0px; font-size:16px" align=center><B>REGISTRATION UNDER SECTION&nbsp;12(b)&nbsp;OF THE</B></P>
<P style="line-height:18.667px; margin:0px; font-size:16px" align=center><B>SECURITIES EXCHANGE ACT OF 1934.</B></P>
<P style="margin:0px" align=center>&nbsp;</P>
<P style="margin:0px" align=right><B>Commission File Number: 1-7928</B></P>
<P style="margin:0px" align=center>&nbsp;</P>
<P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>BIO-RAD LABORATORIES, INC.</B></P>
<P style="margin:0px" align=center><B>NYSE Alternext</B></P>
<P style="margin:0px" align=center>(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)</P>
<P style="margin:0px" align=center>&nbsp;</P>
<P style="margin:0px" align=center><B>1000 Alfred Nobel Drive</B></P>
<P style="margin:0px" align=center><B>Hercules, California 94547</B></P>
<P style="margin:0px" align=center><B>&nbsp;(510) 724-7000</B></P>
<P style="margin:0px" align=center>(Address, including zip code, and telephone number, including area code, of Issuer&#146;s principal executive offices)</P>
<P style="margin:0px" align=center>&nbsp;</P>
<P style="margin:0px" align=center><B>Class A Common Stock and Class B Common Stock</B></P>
<P style="margin:0px" align=center>(Description of class of securities)</P>
<P style="margin:0px" align=center>&nbsp;</P>
<P style="margin:0px">Please place an X in the box to designate the rule&nbsp;provision relied upon to strike the class of securities from listing and registration:</P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px; font-family:Wingdings"><FONT FACE="Wingdings">o</FONT><FONT FACE="Times New Roman"> 17CFR240.12d2-2(a)(1)</FONT></P>
<P style="margin:0px"><FONT FACE="Times New Roman">&nbsp;</FONT></P>
<P style="margin:0px; font-family:Wingdings"><FONT FACE="Wingdings">o</FONT><FONT FACE="Times New Roman"> 17CFR240.12d2-2(a)(2)</FONT></P>
<P style="margin:0px"><FONT FACE="Times New Roman">&nbsp;</FONT></P>
<P style="margin:0px; font-family:Wingdings"><FONT FACE="Wingdings">o</FONT><FONT FACE="Times New Roman"> 17CFR240.12d2-2(a)(3)</FONT></P>
<P style="margin:0px"><FONT FACE="Times New Roman">&nbsp;</FONT></P>
<P style="margin:0px; font-family:Wingdings"><FONT FACE="Wingdings">o</FONT><FONT FACE="Times New Roman"> 17CFR240.12d2-2(a)(4)</FONT></P>
<P style="margin:0px"><FONT FACE="Times New Roman">&nbsp;</FONT></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:28.8px; text-indent:-28.8px; font-family:Wingdings"><FONT FACE="Wingdings">o</FONT></P>
<P style="margin:0px; padding-left:28.8px"><FONT FACE="Times New Roman">Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules&nbsp;to strike the class of securities from listing and/or withdraw registration on the Exchange.</FONT></P>
<P style="margin:0px">&nbsp;</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:28.8px; text-indent:-28.8px; font-family:Wingdings"><FONT FACE="Wingdings">x</FONT></P>
<P style="line-height:normal; margin:0px; padding-left:28.8px; font-size:11.333px"><FONT FACE="Times New Roman">&nbsp;</FONT>Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules&nbsp;of the Exchange and the requirements of 17 CFR 240.12d12-2(c)&nbsp;governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.</P>
<P style="margin:0px">&nbsp;</P>
<P style="margin:0px">Pursuant to the requirements of the Securities Exchange Act of 1934, Bio-Rad Laboratories, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.</P>
<P style="margin:0px; padding-left:10.333px">&nbsp;</P>
<P style="margin-top:6.667px; margin-bottom:6.667px; padding-right:9.6px">Date: &nbsp;October 22, 2008</P>
<P style="margin-top:6.667px; margin-bottom:-16px; padding-left:288px; padding-right:9.6px">By: &nbsp;</P>
<P style="margin-top:0px; margin-bottom:6.667px; padding-left:288px; padding-right:9.6px; text-indent:48px"><U>/s/ Christine A. Tsingos</U></P>
<P style="margin-top:6.667px; margin-bottom:6.667px; padding-right:9.6px; text-indent:336px">Christine A. Tsingos</P>
<P style="margin-top:6.667px; margin-bottom:6.667px; padding-left:288px; padding-right:9.6px; text-indent:48px">Vice President &amp; Chief Financial Officer</P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
</DIV></BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
